Full metadata record
DC FieldValueLanguage
dc.contributor.authorAddisu, Kefyalew Dagnewen_US
dc.contributor.authorHsu, Wei-Hsinen_US
dc.contributor.authorHailemeskel, Balkew Zewgeen_US
dc.contributor.authorAndrgie, Abegaz Tizazuen_US
dc.contributor.authorChou, Hsiao-Yingen_US
dc.contributor.authorYuh, Chiou-Hwaen_US
dc.contributor.authorLai, Juin-Yihen_US
dc.contributor.authorTsai, Hsieh-Chihen_US
dc.date.accessioned2019-12-13T01:09:56Z-
dc.date.available2019-12-13T01:09:56Z-
dc.date.issued2019-10-01en_US
dc.identifier.issn2373-9878en_US
dc.identifier.urihttp://dx.doi.org/10.1021/acsbiomaterials.9b01226en_US
dc.identifier.urihttp://hdl.handle.net/11536/153027-
dc.description.abstractIntegrating anticancer drugs and diagnostic agents in a polymer nanosystem is an emerging and promising strategy for improving cancer treatment. However, the development of multifunctional nano articles (NPs) for an "all-in-one" platform characterized by specific targeting, therapeutic efficiency, and imaging feedback remains an unmet clinical need. In this study, pH-responsive mixed-lanthanide-based multifunctional NPs were fabricated based on simple metal ligand interactions for simultaneous cancer cell imaging and drug delivery. We investigated two new systems of alginate-polydopamine complexed with either terbium/europium or dysprosium/erbium oxide NPs (Tb/Eu@AlgPDA or Dy/Er@AlgPDA NPs). Tb/Eu@AlgPDA NPs were then functionalized with the tumor-targeting ligand folic acid (FA) and loaded with the anticancer drug doxorubicin (DOX) to form FA-Tb/Eu@AlgPDA-DOX NPs. Using such systems, the mussel-inspired property of PDA was introduced to improve tumor targetability and penetration, in addition to active targeting (via FA-folate receptor interactions). Determining the photoluminescence efficiency showed that the Tb/Eu@AlgPDA system was superior to the Dy/Er@AlgPDA system, presenting intense and sharp emission peaks on the fluorescence spectra. In addition, compared to Dy/Er@A1gPDA NPs (82.4%), Tb/Eu@AlgPDA NPs exhibited negligible cytotoxicity with >93.3% HeLa cell viability found in MTT assays at NP concentrations of up to 0.50 mg/mL and high biocompatibility when incubated with zebrafish (Danio rerio) embryos and larvae. The FA-Tb/Eu@AlgPDA-DOX system exhibited a pH-responsive and sustained drug-release pattern. In a spheroid model of HeLa cells, the FA-Tb/Eu@AlgPDA-DOX system showed a better penetration efficiency and spheroid growth-inhibitory effect than free DOX. After incubation with zebrafish embryos, the FA-Tb/Eu@AlgPDA-DOX system also showed improved antitumor efficacies versus the other experimental groups in HeLa tumor cell xenografted zebrafish. Therefore, our results suggested that FA-Tb/Eu@AlgPDA-DOX NPs are promising multifunctional nanocarriers with therapeutic capacity for tumor targeting and penetration.en_US
dc.language.isoen_USen_US
dc.subjectLanthanideen_US
dc.subjectTumor penetrationen_US
dc.subjectPolydopamineen_US
dc.subjectSpheroidsen_US
dc.subjectZebrafishen_US
dc.subjectTheranosticen_US
dc.titleMixed Lanthanide Oxide Nanoparticles Coated with Alginate-Polydopamine as Multifunctional Nanovehicles for Dual Modality: Targeted Imaging and Chemotherapyen_US
dc.typeArticleen_US
dc.identifier.doi10.1021/acsbiomaterials.9b01226en_US
dc.identifier.journalACS BIOMATERIALS SCIENCE & ENGINEERINGen_US
dc.citation.volume5en_US
dc.citation.issue10en_US
dc.citation.spage5453en_US
dc.citation.epage5469en_US
dc.contributor.department生物科技學系zh_TW
dc.contributor.departmentDepartment of Biological Science and Technologyen_US
dc.identifier.wosnumberWOS:000490658800053en_US
dc.citation.woscount0en_US
Appears in Collections:Articles